FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $982,412 | +103.6% | 221,264 | +51.3% | 0.00% | – |
| Q2 2023 | $482,533 | +1004.9% | 146,222 | +854.3% | 0.00% | – |
| Q1 2023 | $43,671 | -96.6% | 15,323 | -91.3% | 0.00% | -100.0% |
| Q4 2022 | $1,282,343 | +92.5% | 176,146 | +113.9% | 0.00% | 0.0% |
| Q3 2022 | $666,000 | -2.5% | 82,339 | -41.0% | 0.00% | 0.0% |
| Q2 2022 | $683,000 | -94.7% | 139,482 | -74.5% | 0.00% | -91.7% |
| Q1 2022 | $12,946,000 | -14.1% | 547,404 | -35.8% | 0.01% | 0.0% |
| Q4 2021 | $15,074,000 | -33.0% | 852,148 | +6.8% | 0.01% | -40.0% |
| Q3 2021 | $22,514,000 | – | 798,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |